Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

Autor: Josep-Maria Ribera, Mireia Morgades, Olga Garcia-Calduch, Maialen Sirvent, Buenaventura Buendia, Marta Cervera, Hugo Luzardo, Jesus-Maria Hernandez-Rivas, Marta Sitges, Irene Garcia-Cadenas, Pau Abrisqueta, Pau Montesinos, Mariana Bastos-Oreiro, Maria-Paz Queipo de Llano, Pilar Bravo, Anna Torrent, Pilar Herrera, Antoni Garcia-Guinon, Ferran Vall-llovera, Josefina Serrano, Maria-Jose Terol, Juan-Miguel Bergua, Ana Garcia-Noblejas, Cristina Barrenetxea, Laura Llorente, Daniel Garcia-Belmonte, Eva Gimeno, Antonia Cladera, Santiago Mercadal, Juan-Manuel Sancho

Publikováno v: Haematologica, Vol 109, Iss 2 (2023)

High dose-intensive or infusional intermediate-dose immunochemotherapy is highly effective treatment for Burkitt lymphoma irrespective of human immunodeficiency virus (HIV) infection. However, toxicities of these regimens are relevant, especially in

Externí odkaz: https://doaj.org/article/411d49da835d412a8fde1dec8785801f

Bone marrowVEGFCexpression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival

Autor: Llorenç Font, Maria Luz Amigo, Carme Pedro, Ana Garrido, David Gallardo, Antoni Garcia-Guiñon, Maria Paz Queipo De Llano, Josep-Maria Ribera, Josep M Marti-Tutusaus, Salut Brunet, Lourdes Escoda, Olga Salamero, Marisa Calabuig, Montserrat Arnan, Vicent Guillem, Carme Talarn, Jordi Sierra, Montserrat Hoyos, Jordi Esteve, Josep F. Nomdedeu, Joan Bargay, Mar Tormo, Blanca Navarro, Marina Díaz-Beyá, Antonia Sampol

Publikováno v: LEUKEMIA & LYMPHOMA
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA

Vascular endothelial growth factor C (VEGFC) stimulates leukemia cell proliferation and survival, and promotes angiogenesis. We studied VEGFC expression in bone marrow samples from 353 adult acute myeloid leukemia (AML) patients and its relationship

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af314581e9ca7b58e24ac0d36841059
https://doi.org/10.1080/10428194.2017.1422858

Validation of the European Leukemianet 2017 Prognostic Classification for Patients with De Novo Acute Myeloid Leukemia Treated with a Risk-Adapted Protocol (CETLAM 2012)

Autor: Lourdes Escoda, Marta Pratcorona, Mónica López-Guerra, Jordi Esteve, Olga Salamero, Josep F. Nomdedeu, Alex Bataller, Rosa Coll, Ana Garrido, Maria Paz Queipo De Llano, Guadalupe Oñate, Ferran Vall-Llovera, Salut Brunet, Joan Bargay, Antonia Sampol, Montserrat Arnan, Montserrat Hoyos, Antonio Garcia-Guiñon, Brayan Merchan, David Gallardo, Marina Díaz-Beyá, Jorge Sierra, Lurdes Zamora, Susana Vives, Francesca Guijarro, Mar Tormo

Publikováno v: Blood. 136:31-32

Introduction The European LeukemiaNet (ELN) 2017 classification for acute myeloid leukemia (AML) stratifies patients in 3 risk categories, according to genetic features of the disease. ELN classification is commonly used to guide post-remission treat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1de279958951ac3c1595991ce70825ef
https://doi.org/10.1182/blood-2020-140670

Outcome of Adults with Relapsed T-Cell Acute Lymphoblastic Leukemia (T-ALL) Included in Minimal Residual Disease (MRD)-Oriented Trials

Autor: Maria Paz Queipo De Llano, Cristina Gil, Anna Torrent, Alberto Orfao, Eulàlia Genescà, Mireia Morgades, Eduardo Cerello Chapchap, María-Luz Amigo, Teresa Bernal del Castillo, María Teresa Artola, Mar Tormo, Josep-Maria Ribera, Juana Ciudad, Ferran Vall-Llovera, María José Sánchez, Antonia Cladera, Pere Barba, Lourdes Amador Barciela, Alberto Gimenez Conca, Beatriz Soria, José González-Campos, Jordi Ribera, Antoni Garcia-Guiñon, Rosa Coll, Irene García-Cadenas

Publikováno v: Blood. 136:6-7

Introduction and objective. Despite a high complete remission (CR) rate obtained with frontline therapy most adults with T-ALL eventually relapse. Although promising therapies are emerging, salvage options for T-ALL are currently limited. Little is k

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::936c25e94799f045e5135803762987d8
https://doi.org/10.1182/blood-2020-137383

Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach

Autor: Granada Perea, Eulàlia Puigdecanet, Elena Bussaglia, Jorge Sierra, Elena Serrano, Maria Paz Queipo De Llano, Lara Nonell, Maite Carricondo, Camino Estivill, Juan José Hernández, Josep F. Nomdedeu, Lurdes Zamora, Antoni Garcia, Josep-Maria Ribera, Josep M Marti-Tutusaus, I Sánchez-Ortega, Mar Tormo, Francesc Solé, Anna Aventin, Maria Salut Brunet

Publikováno v: Hematological Oncology. 35:778-788

Deoxyribonucleic acid microarrays allow researchers to measure mRNA levels of thousands of genes in a single experiment and could be useful for diagnostic purposes in patients with acute myeloid leukaemia (AML). We assessed the feasibility of the AML

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2471ec56ef3348091853cc3fbe62c3ed
https://doi.org/10.1002/hon.2304